Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β.

Brain : a journal of neurology - 1 Jul 2012

Koffie Robert M, Hashimoto Tadafumi, Tai Hwan-Ching, Kay Kevin R, Serrano-Pozo Alberto, Joyner Daniel, Hou Steven, Kopeikina Katherine J, Frosch Matthew P, Lee Virginia M, Holtzman David M, Hyman Bradley T, Spires-Jones Tara L

Abstract excerpt

The apolipoprotein E ε4 gene is the most important genetic risk factor for sporadic Alzheimer's disease, but the link between this gene and neurodegeneration remains unclear. Using array tomography, we analysed >50000 synapses in brains of 11 patients with Alzheimer's disease and five non-demente...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid beta-Peptides
Share to Apolipoprotein E3

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoprotein E4

Share to Nerve Degeneration

Share to Plaque, Amyloid

Share to Primary Cell Culture

Share to Protein Transport

Share to Synapses

Source

Open in PubMed Open full text

Identifiers

PMID: 22637583
DOI: 10.1093/brain/aws127
PMCID: PMC3381721

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22637583-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β.PMID 22637583Read ↗

Clusterin accumulates in synapses in Alzheimer’s disease and is increased in apolipoprotein E4 carriersSemantic proximity Read ↗

Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotypeSemantic proximity Read ↗

Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer’s diseaseSemantic proximity Read ↗

Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotypeSemantic proximity Read ↗

Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer's diseaseSemantic proximity Read ↗

Apolipoprotein E in Synaptic Plasticity and Alzheimer’s Disease: Potential Cellular and Molecular MechanismsSemantic proximity Read ↗

Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease.Semantic proximity Read ↗

APOE ε4 is associated with decreased synaptic density in cognitively impaired participants.Semantic proximity Read ↗

Amyloid-β oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's diseaseSemantic proximity Read ↗

Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.Semantic proximity Read ↗

Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2.Semantic proximity Read ↗

Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.